Company intelligence / Profile preview

FB Dermatology

San Benedetto del Tronto, Marche, Italy

Ownership: Private
Development stage: Other

Overview

FB Dermatology's FLE technology (Kleresca) represents a unique, patented, non-invasive method for skin stimulation and tissue regeneration. Clinical results support safety and efficacy for skin conditions such as acne, rosacea, and wound care. LumiHeal (wound healing device) is part of the marketed product portfolio.

Therapeutic areas: Dermatology
Modalities: DeviceNon-pharmacological therapyPhotobiomodulation (via Fluorescent Light Energy Technology / FLETECH)
Industry: Therapeutic Medical Devices

Partnerships

Kane Biotech (pending acquisition)co-development with healthcare professionals and disruptive Biotech partners

Beyond the preview

Go deeper on FB Dermatology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FB Dermatology.

Explore the full profile